The Annex to Implementing Decision (EU) 2021/1195 is amended in accordance with the Annex to this Decision.
資料由法律人 LawPlayer整理提供·EU law / curated by LawPlayer from EUR-Lex
Commission Implementing Decision (EU) 2024/2625 of 8 October 2024 amending Implementing Decision (EU) 2021/1195 as regards harmonised standards for aseptic processing of health care products and clinical performance studies using specimens from human subjects
This Decision shall enter into force on the day of its publication in the Official Journal of the European Union .
Schedules & Appendices
ANNEX
In the Annex to Implementing Decision (EU) 2021/1195, the following entries are added:
No
Reference of the standard
‘14.
EN ISO 13408-1:2024
Aseptic processing of health care products – Part 1: General requirements (ISO 13408-1:2023)
15.
EN ISO 20916:2024
In vitro diagnostic medical devices – Clinical performance studies using specimens from human subjects – Good study practice (ISO 20916:2019)’.
Cite this act
Commission Implementing Decision (EU) 2024/2625 of 8 October 2024 amending Implementing Decision (EU) 2021/1195 as regards harmonised standards for aseptic processing of health care products and clinical performance studies using specimens from human subjects (EUR-Lex). Retrieved via LawPlayer, https://lawplayer.com/eu/act/32024D2625
© European Union, https://eur-lex.europa.eu, 1998-2026. Reuse authorised under Commission Decision 2011/833/EU, provided the source is acknowledged.
本頁資料來源:EUR-Lex·整理提供:法律人 LawPlayer· lawplayer.com